|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.57 HKD | -1.35% |
|
+5.02% | -9.62% |
| 18/06 | Sinopharm Group Co. Ltd. Approves Ordinary Final Dividend for the Year Ended 31 December 2025, Payable on 18 August 2026 | CI |
| 27/04 | Earnings Season, Tehran Proposal Lift Asian Stock Markets | MT |
EPS & Dividend: Sinopharm Group Co. Ltd.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 0.75 | 0.82 | 0.87 | 0.68 | 0.69 | 0.7265 | 0.7914 | 0.8331 |
| Rate of return | 5.43% | 4.67% | 4.69% | 3.4% | 3.95% | 4.78% | 5.21% | 5.48% |
| EPS 2 | 2.49 | 2.73 | 2.9 | 2.26 | 2.29 | 2.455 | 2.677 | 2.943 |
| Distribution rate | 30.1% | 30% | 30% | 30.1% | 30.1% | 29.6% | 29.6% | 28.3% |
| Reference price 2 | 13.82 | 17.55 | 18.56 | 20.02 | 17.47 | 15.19 | 15.19 | 15.19 |
| Nbr of stocks (in thousands) | 31,20,656 | 31,20,656 | 31,20,656 | 31,20,656 | 31,20,656 | 31,20,656 | - | - |
| Announcement Date | 20/03/22 | 26/03/23 | 24/03/24 | 23/03/25 | 22/03/26 | - | - | - |
1CNY in Million2CNY
Estimates
Past dividends: Sinopharm Group Co. Ltd.
| 23/06/2026 | Ex-dividend date - 0.79 HKD | 09:30 am |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 4.78% | 5.21% | 6.19x | 0.53x | 0.1x | |
| 0.4% | 0.42% | 19.89x | -47.39x | 0.24x | |
| 0.9% | 0.92% | 29.37x | -23.03x | 0.23x | |
| 1.35% | 1.65% | 45.92x | 6.77x | 3.24x | |
| 2.61% | 2.87% | 11.53x | 0.77x | 0.2x | |
| 2.52% | 2.81% | 13.41x | 1.92x | 1.03x | |
| 3.5% | 3.58% | 9.39x | 1.48x | 1.76x | |
| 2.85% | 2.99% | 25.04x | 2.89x | 1.22x | |
| 4.09% | 4.36% | 10.93x | 0.86x | 0.12x | |
| 2.39% | 2.47% | 14.25x | 0.77x | - | |
| Average | 2.54% | 2.73% | 18.59x | -5.44x | 0.91x | |
| Weighted average by Cap. | 1.17% | 1.27% | 23.62x | -26.11x | 0.66x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition